DRD3 Antikörper (AA 213-329)
Kurzübersicht für DRD3 Antikörper (AA 213-329) (ABIN7149475)
Target
Alle DRD3 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 213-329
-
Kreuzreaktivität
- Human
-
Aufreinigung
- Antigen Affinity Purified
-
Immunogen
- Recombinant Human D(3) dopamine receptor protein (213-329AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Recommended dilution: WB:1:200-1:1000, IHC:1:20-1:200,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- DRD3 (Dopamine Receptor D3 (DRD3))
-
Andere Bezeichnung
- DRD3
-
Hintergrund
-
Background: Dopamine receptor whose activity is mediated by G proteins which inhibit adenylyl cyclase. Promotes cell proliferation.
Aliases: 3dopamine receptor antibody, D antibody, D(3) dopamine receptor antibody, Dopamine D3 receptor antibody, Dopamine receptor D3 antibody, DRD3 antibody, DRD3_HUMAN antibody, ETM1 antibody, FET1 antibody
-
UniProt
- P35462
-
Pathways
- Regulation of Systemic Arterial Blood Pressure by Hormones, cAMP Metabolic Process, Regulation of G-Protein Coupled Receptor Protein Signaling, Proton Transport, Negative Regulation of Transporter Activity
Target
-